Assembly Biosciences (ASMB) Misses Q2 EPS by 133c

Assembly Biosciences (NASDAQ: ASMB) reported Q2 EPS of ($1.33). Revenue for the quarter came in at $9.62 million.

For earnings history and earnings-related data on Assembly Biosciences (ASMB) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• Boeing wins $121 million Navy contract for P-8A upgrades